Klavs Jensen - May 25, 2022 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role: Director
Signature: /s/ Lawrence Knopf, Attorney-in-Fact for Klavs F. Jensen
Stock symbol: SQZB
Transactions as of: May 25, 2022
Transactions value $: $50,428
Form type: 4
Date filed: 5/27/2022, 05:01 PM
Previous filing: Jun 17, 2021
Next filing: Jun 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SQZB	Common Stock	Purchase	$50.4K	+14.3K	+4.23%	$3.52^*	353K	May 25, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Includes 1 share of common stock inadvertently omitted from the amount reported in Columns 4 and 5 of the Form 4 filed by the Reporting Person on November 3, 2020 as a result of an error in calculating the aggregation of fractional shares resulting from conversion.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 1 share of common stock inadvertently omitted from the amount reported in Columns 4 and 5 of the Form 4 filed by the Reporting Person on November 3, 2020 as a result of an error in calculating the aggregation of fractional shares resulting from conversion.